JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Net interest income | -18.10%7.39B | -10.64%5.3B | -3.04%2.86B | -4.20%11.74B | -4.63%9.02B | -5.12%5.93B | -4.34%2.95B | 2.55%12.25B | 8.23%9.46B | 8.27%6.25B |
-Interest income | -9.11%17.12B | -5.00%11.78B | -1.15%6.08B | -1.19%24.76B | -1.55%18.83B | -2.47%12.4B | -3.19%6.15B | -1.99%25.06B | 0.46%19.13B | 0.77%12.71B |
-Interest expense | 0.84%-9.73B | -0.16%-6.48B | -0.59%-3.23B | -1.69%-13.02B | -1.46%-9.81B | -0.09%-6.47B | 2.11%-3.21B | 5.97%-12.8B | 6.12%-9.67B | 5.56%-6.47B |
Net service income | -20.89%349.85M | -17.42%266M | -31.62%110.41M | -26.80%578.93M | -19.25%442.23M | -23.18%322.1M | -30.56%161.46M | -36.30%790.9M | -44.86%547.68M | -41.98%419.31M |
-Service income | -17.69%454.81M | -14.24%339.71M | -25.56%143.61M | -21.52%735.88M | -24.57%552.57M | -22.74%396.11M | -28.18%192.92M | -33.44%937.71M | -33.99%732.51M | -35.44%512.71M |
-Service charge | 4.88%-104.96M | 0.41%-73.71M | -5.53%-33.2M | -6.91%-156.95M | 40.30%-110.34M | 20.76%-74.02M | 12.84%-31.46M | 12.20%-146.81M | -58.87%-184.83M | -30.76%-93.4M |
Net transaction income | 5.88%616.52M | 12.22%450.28M | 240.28%152.24M | -46.40%781.75M | -61.89%582.28M | -42.20%401.24M | -77.14%44.74M | 112.03%1.46B | 175.79%1.53B | 148.57%694.19M |
Securities and investments income | 87.63%635.72M | 72.28%333.61M | 87.66%244.51M | -14.12%493.88M | 78.82%338.81M | 9.90%193.65M | 242.60%130.29M | -33.92%575.05M | 85.79%189.47M | 24.78%176.21M |
Special items of operating revenue | -12.19%73.55M | -1.84%59.71M | 254.76%44.37M | -28.66%105.25M | -18.31%83.76M | 109.90%60.83M | 216.58%12.51M | 136.82%147.53M | 129.79%102.54M | -12.41%28.98M |
Operating revenue | -13.41%9.06B | -7.22%6.41B | 3.43%3.41B | -10.03%13.7B | -11.49%10.46B | -8.74%6.9B | -3.67%3.29B | 2.80%15.23B | 13.35%11.82B | 8.92%7.56B |
Operating expenses - before deducting impairment | -3.86%-2.44B | -9.26%-1.66B | 1.48%-659.53M | -5.52%-3.86B | -7.46%-2.35B | -11.78%-1.52B | -17.10%-669.45M | -2.53%-3.66B | 1.00%-2.18B | 1.27%-1.36B |
Operating profit before deducting impairment | -18.40%6.62B | -11.88%4.74B | 4.68%2.75B | -14.94%9.84B | -15.78%8.12B | -13.24%5.38B | -7.83%2.63B | 2.89%11.57B | 17.19%9.64B | 11.45%6.2B |
Impairment and provisions | 15.65%-4.05B | 0.58%-2.86B | -40.53%-1.59B | 6.75%-8.08B | 7.58%-4.8B | 2.77%-2.88B | 16.00%-1.13B | -19.23%-8.66B | -29.71%-5.19B | -22.75%-2.96B |
-Impairment losses of other assets | 15.65%-4.05B | 0.58%-2.86B | -40.53%-1.59B | 6.75%-8.08B | 7.58%-4.8B | 2.77%-2.88B | 16.00%-1.13B | -19.23%-8.66B | -29.71%-5.19B | -22.75%-2.96B |
Operating profit after deducting impairment | -22.39%2.58B | -24.88%1.88B | -22.46%1.16B | -39.31%1.77B | -25.34%3.32B | -22.80%2.5B | -0.51%1.49B | -26.93%2.91B | 5.34%4.45B | 2.81%3.24B |
Operating expenses - after deducting impairment | ---10.98M | ---7.24M | ---3.49M | ---8.54M | ---- | ---- | ---- | ---- | ---- | ---- |
-Special items of operating expenditure | ---10.98M | ---7.24M | ---3.49M | ---8.54M | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit | -22.72%2.57B | -25.17%1.87B | -22.69%1.15B | -39.61%1.76B | -25.34%3.32B | -22.80%2.5B | -0.51%1.49B | -26.93%2.91B | 5.34%4.45B | 2.81%3.24B |
Share of profits of associates | -143.06%-10.17M | -115.61%-3.7M | -106.06%-1.48M | 82.99%-17.35M | 125.27%23.62M | 706.46%23.71M | 750.87%24.42M | -1,592.31%-102.01M | -832.40%-93.45M | -58.53%2.94M |
Earning before tax | -23.57%2.56B | -26.02%1.87B | -24.03%1.15B | -38.03%1.74B | -23.19%3.35B | -22.14%2.53B | 0.92%1.52B | -29.61%2.81B | 2.82%4.36B | 2.67%3.25B |
Tax | 46.02%-268.13M | 46.56%-220.46M | 41.72%-162.29M | 157.82%119.84M | 38.83%-496.7M | 32.76%-412.51M | 0.70%-278.47M | 64.88%-207.28M | -4.05%-811.95M | 1.24%-613.47M |
After-tax profit from continuing operations | -19.65%2.29B | -22.01%1.65B | -20.06%991.22M | -28.48%1.86B | -19.61%2.85B | -19.67%2.11B | 1.29%1.24B | -23.48%2.6B | 2.54%3.54B | 3.63%2.63B |
Earning After tax | -19.65%2.29B | -22.01%1.65B | -20.06%991.22M | -28.48%1.86B | -19.61%2.85B | -19.67%2.11B | 1.29%1.24B | -23.48%2.6B | 2.54%3.54B | 3.63%2.63B |
Minority profit | -54.33%44.83M | -18.57%55.25M | -54.14%23.78M | -94.73%9.36M | -30.07%98.17M | -32.92%67.85M | -10.14%51.85M | 3.42%177.64M | 12.91%140.38M | 17.40%101.15M |
Profits attributable to shareholders | -18.41%2.24B | -22.12%1.59B | -18.57%967.45M | -23.62%1.85B | -19.18%2.75B | -19.14%2.05B | 1.86%1.19B | -24.92%2.42B | 2.15%3.4B | 3.15%2.53B |
Basic earnings per share | -16.67%0.25 | -21.74%0.18 | -15.38%0.11 | -6.25%0.15 | -18.92%0.3 | -25.81%0.23 | -7.14%0.13 | -51.52%0.16 | -7.50%0.37 | 3.33%0.31 |
Diluted earnings per share | -16.67%0.25 | -21.74%0.18 | -15.38%0.11 | -6.25%0.15 | -18.92%0.3 | -25.81%0.23 | -7.14%0.13 | -51.52%0.16 | -7.50%0.37 | 3.33%0.31 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.